Several hundred Cordis(r) employees gathered at a Fremont location on Thursday, January 10, to tour their future home and examine the facilities. Cordis(r), a Johnson and Johnson Company, is considered a leader in vascular disease management providing products such as drug-eluting stents and catheters. Until the formal announcement of the move, information about consolidation of scattered Bay Area facilities was confidential. The Fremont campus located at 6500 Paseo Padre Parkway in the Ardenwood area directly opposite Coyote Hills Regional Park includes nearly 700,000 square feet comprised of three buildings totaling 290,000 square feet around a 2-acre central quad.

Completed in 1998, the buildings have been renovated to include state-of-the-art amenities including laboratories, meeting rooms, fiber interconnectivity, a full-service cafeteria, health clinic and fitness center. Orientation included introductory remarks by company officials, a self-guided tour of the facilities and informational tables courtesy of Rideshare and Tri-City Voice Newspaper.

Employee relocation to the new facility is planned in stages over the next couple of years; few changes except location are slated for the company. It was noted that this move would not include any change in organization, projects, portfolio or priorities. The facilitating nature of bringing those groups together and efficiencies derived from a centralized location were cited. As of March 2007, Cordis facilities in the Bay Area were housed in seven different buildings at five different sites including Fremont, Redwood City, Menlo Park and Sunnyvale. The Fremont site was viewed as "by far the most promising with the greatest opportunities for immediate benefits and future growth."

Management was asked during the informational meeting if future expansion plans might include additional Johnson and Johnson companies. With expansion capability of up to an additional 370,000 square feet, the answer was phrased as a definite possibility.